BBVA USA Bancshares’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,409
Closed -$220K 542
2020
Q4
$220K Sell
5,409
-582
-10% -$21.8K 0.01% 509
2020
Q3
$219K Sell
5,991
-2,311
-28% -$83.6K 0.01% 483
2020
Q2
$281K Buy
+8,302
New +$226K 0.02% 455

Other funds holding GMAB

BBVA USA Bancshares's GMAB Position: Q1 2021 in Review

BBVA USA Bancshares sold out of Genmab (GMAB) in Q1 2021, closing a stake of 5,409 shares — an estimated $220K sold.

BBVA USA Bancshares first reported a position in GMAB in Q2 2020 and held it in 3 quarters. The position peaked at $281K in Q2 2020. 210 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • BBVA USA Bancshares reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • BBVA USA Bancshares sold 5,409 Genmab shares in Q1 2021, an estimated $220K.
  • BBVA USA Bancshares first reported a position in Genmab in Q2 2020 and held it in 3 quarters.
  • BBVA USA Bancshares's Genmab position peaked at $281K in Q2 2020.
  • 210 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.